VILON 20 MG

Dragon Pharma Vilon 20 mg – Synthetic Dipeptide for Immune and Chromatin Research

Dragon Pharma Vilon 20 mg is a synthetic dipeptide with the amino acid sequence Lys-Glu (KE). Developed as part of the well-characterized Khavinson class of short peptide bioregulators, this compound has been investigated in laboratory and animal models for its potential role in immune modulation, chromatin remodeling, and gene expression changes associated with cellular aging.

Each vial contains 20 mg of lyophilized Vilon in a 2 mL format, requiring reconstitution with bacteriostatic water before use. Vilon represents a minimal yet biologically active peptide tool for investigating fundamental cellular processes including immune function, epigenetic regulation, and the molecular basis of cellular aging. For related research compounds, explore our peptides category and specifically Epitalon 50 mg for complementary aging and telomere research applications.

What Makes Vilon Valuable in Research?

Vilon is a remarkably short peptide consisting of just two amino acids, yet it demonstrates significant biological activity in research models. The Lys-Glu dipeptide has been studied for its ability to influence immune cell function, modulate chromatin structure, and affect gene expression patterns associated with cellular aging. Its simplicity and specificity make it a valuable tool for investigating the molecular mechanisms of peptide bioregulation.

Researchers value Vilon for its fundamental role in studying peptide-mediated cellular regulation. Its ability to influence immune responses and chromatin dynamics provides insights into the mechanisms that govern cellular function, gene expression, and the aging process. For investigators exploring other aspects of immune function, Thymosin Alpha-1 offers complementary research avenues in immune system regulation.

Current scientific literature on Khavinson peptides, including Vilon, can be accessed through the PubMed database, where researchers can review peer-reviewed studies on their biological activity and experimental applications.

Key Research Applications for Dragon Pharma Vilon

• ✔ Investigation of immune modulation and function
• ✔ Evaluation of chromatin remodeling and epigenetic regulation
• ✔ Research on gene expression changes in cellular aging
• ✔ Studies of peptide bioregulation in immune cells
• ✔ Preclinical models of aging and immune function

Product Details

Dosage & Usage Guidelines

Reconstitution Protocol

• ✔ Use sterile bacteriostatic water for injection
• ✔ Add appropriate volume to achieve desired concentration
• ✔ Swirl gently to dissolve – do not shake vigorously
• ✔ Store reconstituted solution at 2–8°C

Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 20 mg format allows for flexible dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.

Typical Research Parameters

In research settings, Vilon is typically administered via subcutaneous or intraperitoneal injection. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.

• ✔ Commonly used in immune function and aging studies
• ✔ Often combined with histological and molecular analysis
• ✔ Used to investigate chromatin remodeling and gene expression
• ✔ Research models include immune cells and aging paradigms

Factors to Consider in Research Protocols

• Short-chain dipeptide with specific bioregulatory properties
• Reconstitution stability is limited; prepare fresh solutions for each use
• Individual variation in response may be observed across subjects
• Storage conditions significantly impact peptide stability

Lab Testing & Batch Transparency

Lab status

COA pending release

Third-party analytical testing (COA) for Dragon Pharma Vilon 20 mg is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.

Testing Status

Pending

COA Availability

Not yet published

Batch Verification

In progress

Update

Coming soon

Transparency note: Dragon Pharma publishes batch-specific lab reports once analytical testing is completed and verified.

Awaiting COA

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions